MMSL 2015, 84(4):152-165 | DOI: 10.31482/mmsl.2015.019

SELECTED VIRAL HEMORRHAGIC FEVERSReview article

Vanda Boštíková ORCID...1*, Miloslav Salavec2, Radek Sleha ORCID...1, Petr Prášil3, Jan Marek ORCID...1,4, Ondřej Soukup ORCID...1,4, Kamil Kuča ORCID...1,4
1 Faculty of Military Health Sciences, University of, Hradec Kralove, Czech Republic
2 Department of Dermatovenerology, Charles University Medical School and University Hospital, Hradec Kralove, Czech Republic
3 Department of Infectious Diseases, Charles University, Medical School and Univeristy Hospital, Hradec Kralove, Czech Republic
4 Biomedical Research Center, University Hospital of Hradec Kralove, Hradec Kralove, Czech Republic

Group of viral hemorrhagic fevers (VHF) present a range of disorders from relatively moderately serious to human life threatening entities whose mortality reaches high levels. There are classified as acute viral febrile diseases characterized by nausea, myalgia and fatigue, dominating with general alteration of vessel permeability and regulation. Symptoms of bleeding often occur, particularly in severe cases which are usually diffuse and present a symptom of general vessel injury rather than life-threatening condition.

Keywords: viral hemorrhagic fevers; Lassa virus; Junin virus; Machupo virus; Omsk hemorrhagic fever; Kyasanur forest fever; yellow fever, dengue; Ebola; Marburg; Rift Valley fever virus; hantaviruses

Received: May 24, 2015; Revised: November 14, 2015; Published: December 4, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Boštíková, V., Salavec, M., Sleha, R., Prášil, P., Marek, J., Soukup, O., & Kuča, K. (2015). SELECTED VIRAL HEMORRHAGIC FEVERS. MMSL, 84(4), 152-165. doi: 10.31482/mmsl.2015.019
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. http://phil.cdc.gov/phil/details.asp?pid=10816
    2. Fehling, S.K. Multifunctional Nature of the Arenavirus RING Finger Protein Z. Viruses. 2012, 4(11), 2973-3011. Go to original source... Go to PubMed...
    3. WHO, Cairo.Viral hemorrhagic fever. Available from: http://www.who.int/mediacentre/factsheets/fs208/en/index.html, 2011.
    4. Peters, C.J. Patients infected with high-hazard viruses: scientific basis for infection controls. Arch. Virol. Suppl. 1996, 11, 141 - 168. Go to original source... Go to PubMed...
    5. Marty, A.M. Viral hemorrhagic fevers. Clin. Lab. Med. 2006, 26, 345 - 386. Go to original source... Go to PubMed...
    6. Peters, C.J.Overview of viral hemorrhagic fevers. In: Guerrant, R.L., Walker, D.H., Weller, P.F.: Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Churchill Livingstone.2006, 756 - 761.
    7. McCormik, J.B. Lassa fever. Curr.Top Microbiol. Immunol. 2002, 262, 75 - 109.
    8. Monath, T.P. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science. 1974, 185, 263-265. Go to original source... Go to PubMed...
    9. Guerrant, R.L.Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Churchill Livingstone. 2006,756 - 761.
    10. Mupapa, K. Treatment of Ebola hemorrhagic fever with blood tramsfusion from convalescent patients. J. Infect. Dis. 1999, 1, S18 - S 23. Go to original source... Go to PubMed...
    11. Khan, A.S. A new twist for Ebola: Reston-infected pigs in the Philippines. Public Health Matters. http://www.cdc.gov/nczved/blog/2009/01/05/ebola-reston.html, 2009.
    12. Jones, S.M. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat.Med. 2005, 11(7), 786 - 790. Go to original source... Go to PubMed...
    13. Leffel, E. K. Marburg and Ebola viruses as aerosol threats. Biosec. Bioterr.: Biodefense Strat. Pract. Sci. 2004, 2(3), 1 - 6.
    14. Ozkurt, Z.Crimea n-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J. Infect. 2006, 52, 207 - 215. Go to original source... Go to PubMed...
    15. Lacy, M.D.Viral hemorrhagic fever. Adv Pediatr Infect Dis. 1996, 12, 21-53.
    16. Vapalahti, O. Hantavirus infections in Europe. Lancet Infect. Dis. 2003, 3, 653 - 661. Go to original source... Go to PubMed...
    17. Pejcoh, M.Hantaviruses and their infections. KMIL. 2003, 1(9), 4 - 11.
    18. Khan, A.S. Filoviral haemorrhagic fevers. Br. Med. Bull. 1988, 54 (3), 675-692. Go to original source... Go to PubMed...
    19. Lub, M.. Clinical-virusological characteristics of disease in monkeys in infected with the Marburg virus by an airborne route. Vopr. Virusol. 2005, 40(3), 119 - 121.
    20. Haas, W.H. Imported Lassa and management of contact persons. Clin. Infect. Dis. 2003, 36(10), 1254 -1258. Go to original source... Go to PubMed...
    21. Demby, A.H. Early diagnosis of Lassa fever by reverse transcription PCR. J. Clin. Microbiol. 1994, 32(12), 2898-2903. Go to original source... Go to PubMed...
    22. Splino, M. Ebola virus. Vakcinologie. 2012, 2, 80-81.
    23. www.who.org
    24. Peterson, A. Ecologic and geographic distribution of filovirus disease. Emerg Infect Dis. 2004, 10, 40-47. Go to original source... Go to PubMed...
    25. Suzuki, Y. The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol. 1997, 14: 800 - 806. Go to original source... Go to PubMed...
    26. Pigott, D.M.Mapping the zoonotic niche of Ebola virus disease in Africa. eLife. 2014, 3:e04395. DOI: 10.7554/eLife.04395. Go to original source... Go to PubMed...
    27. Brashares, J.S.Economic and geographic drivers of wildlife consumption in rural Africa. Proceedings of the National Academy of Sciences of USA. 2011,108:13931-6. doi: 10.1073/pnas.1011526108. Go to original source... Go to PubMed...
    28. Leroy E.M.Fruit bats as reservoirs of Ebola virus. Nature. 2005, 438: 575-576. Go to original source... Go to PubMed...
    29. Center for disease control and prevention. Chronology of Ebola hemorrhagic fever outbreaks. Available from: http://www.cdc.gov/vhf/ebola/resources/outbreak-table.html, 2014.
    30. WHO.Ebola Reston found in domestic pigs in the Philippines. Frequently asked questions about Ebola Reston virus and human health. http://www.wpro.who.int/health_topics/ebola_reston/EbolaReston_FAQ.htm, 2009.
    31. CDC. Managment of patiens with suspected viral hemorrhagic fever. Morb. Mort. Wk. Rep.37 (S-3). 16s. http://www.cdc.gov/mmwr/preview/mmwrhtml/00037085.htm, 1988.
    32. CDC. Management of patients with suspected VHF. MMWR. 1998, 37, 1-16, 33.
    33. BAUSCH D.G., et al. Risk factor for Marburg HF,Congo. Emerg Infect Dis.no. 2003, 9, 1531-1537 Go to original source... Go to PubMed...
    34. EMORY Medicine, special issue. 2014, 1 -35.
    35. Borio L. Medical and public health management. JAMA. 2002, 287, 2391-405.
    36. Sangrinpati J.L. Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch. Virol. 2010, 155:2035-2039. Go to original source... Go to PubMed...
    37. http://bit.ly/partners-in-health.
    38. Geisbert, T.W. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis. 2002, 8, 503- 507. Go to original source... Go to PubMed...
    39. SwanepolL R.Experimental inoculation of plants and animals with Ebola virus.Emerg. Infect. Dis. 1996, 2, 321 - 325. Go to original source... Go to PubMed...
    40. http://hackingfamily.com/Landfalls/Sri_Lanka/Highlands.htm

    Return to the content